Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Organized screening detects breast cancer at earlier stage regardless of molecular phenotype.

Journal of cancer research and clinical oncology - 1 Sept 2018

Holloway Claire M B, Jiang Li, Whitehead Marlo, Racz Jennifer M, Groome Patti A

Abstract excerpt

PURPOSE: Mortality reduction attributable to organized breast screening is modest. Screening may be less effective at detecting more aggressive cancers at an earlier stage. This study was conducted to determine the relative efficacy of screening mammography to detect cancers at an earlier stage by molecular phenotype. METHODS: We identified 2882 women with primary invasive breast cancer diagnosed between January...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cross-Sectional Studies
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mammography

Share to Neoplasm Staging

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to Triple Negative Breast Neoplasms

Source

Identifiers

PMID: 29909564
DOI: 10.1007/s00432-018-2687-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Organized screening detects breast cancer at earlier stage regardless of molecular phenotype.PMID 29909564Read ↗

Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.Semantic proximity Read ↗

Survival and Disease-Free Survival by Breast Density and Phenotype in Interval Breast Cancers.Semantic proximity Read ↗

Risk factors and tumor characteristics of interval cancers by mammographic density.Semantic proximity Read ↗

Comparison of clinical-pathologic characteristics and outcomes of true interval and screen-detected invasive breast cancer among participants of a Canadian breast screening program: a nested case-control study.Semantic proximity Read ↗

Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in SpainSemantic proximity Read ↗

Phenotypic characterization and risk factors for interval breast cancers in a population-based breast cancer screening program in Barcelona, Spain.Semantic proximity Read ↗

A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors.Semantic proximity Read ↗

Complementary approaches to assessing risk factors for interval breast cancer.Semantic proximity Read ↗

Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction.Semantic proximity Read ↗

Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancers.Semantic proximity Read ↗

Triple-Negative versus Non-Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study.Semantic proximity Read ↗

Breast cancer surveillance for BRCA1/2 mutation carriers - is "early detection" early enough?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.